Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence D True

Showing results (71-80 of 204) with videos related to

Pageof 21
Sort By:
Bone|May 9, 2015
Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironmentRebecca S Arnold, Stacey A Fedewa, Michael Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15Chung-Ying Huang, Tomasz M Beer, Celestia S Higano, et al.
The Prostate|June 29, 2010
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viabilityColm Morrissey, Alex Dowell, Theodore D Koreckij, et al.
Nature Methods|April 8, 2015
Sequencing small genomic targets with high efficiency and extreme accuracyMichael W Schmitt, Edward J Fox, Marc J Prindle, et al.
Angewandte Chemie (International Ed. in English)|June 9, 2016
Cross-Platform DNA Encoding for Single-Cell Imaging of Gene ExpressionPavel Zrazhevskiy, Shreeram Akilesh, Wanyi Tai, et al.
The Prostate|September 27, 2008
The accumulation of versican in the nodules of benign prostatic hyperplasiaLawrence D True, Sarah Hawley, Thomas H Norwood, et al.
Asian Journal of Urology|December 22, 2017
Mismatch repair enzyme expression in primary and castrate resistant prostate cancerBelinda Nghiem, Xiaotun Zhang, Hung-Ming Lam, et al.
Cancer Research|June 4, 2008
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growthR Bruce Montgomery, Elahe A Mostaghel, Robert Vessella, et al.
The Prostate|March 22, 2007
Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancerPeter C Black, Gregory J Mize, Peter Karlin, et al.
Plos One|November 25, 2011
Androgen receptor variants occur frequently in castration resistant prostate cancer metastasesXiaotun Zhang, Colm Morrissey, Shihua Sun, et al.
Pageof 21

Showing results (71-80 of 204) with videos related to

Sort By:
Pageof 21
Bone|May 9, 2015
Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironmentRebecca S Arnold, Stacey A Fedewa, Michael Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15Chung-Ying Huang, Tomasz M Beer, Celestia S Higano, et al.
The Prostate|June 29, 2010
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viabilityColm Morrissey, Alex Dowell, Theodore D Koreckij, et al.
Nature Methods|April 8, 2015
Sequencing small genomic targets with high efficiency and extreme accuracyMichael W Schmitt, Edward J Fox, Marc J Prindle, et al.
Angewandte Chemie (International Ed. in English)|June 9, 2016
Cross-Platform DNA Encoding for Single-Cell Imaging of Gene ExpressionPavel Zrazhevskiy, Shreeram Akilesh, Wanyi Tai, et al.
The Prostate|September 27, 2008
The accumulation of versican in the nodules of benign prostatic hyperplasiaLawrence D True, Sarah Hawley, Thomas H Norwood, et al.
Asian Journal of Urology|December 22, 2017
Mismatch repair enzyme expression in primary and castrate resistant prostate cancerBelinda Nghiem, Xiaotun Zhang, Hung-Ming Lam, et al.
Cancer Research|June 4, 2008
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growthR Bruce Montgomery, Elahe A Mostaghel, Robert Vessella, et al.
The Prostate|March 22, 2007
Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancerPeter C Black, Gregory J Mize, Peter Karlin, et al.
Plos One|November 25, 2011
Androgen receptor variants occur frequently in castration resistant prostate cancer metastasesXiaotun Zhang, Colm Morrissey, Shihua Sun, et al.
Pageof 21